1. Causes behind error rates for predictive biomarker testing: the utility of sending post-EQA surveys

   Keppens, C., Schuuring, E. & Dequeker, E. M. C., 23-Nov-2020, In : Virchows Archiv : an International Journal of Pathology.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Managing Deviating EQA Results: A Survey to Assess the Corrective and Preventive Actions of Medical Laboratories Testing for Oncological Biomarkers

   Keppens, C., Schuuring, E. & Dequeker, E. M., 2020, In : Diagnostics. 10, 10

   Research output: Contribution to journal › Article › Academic › peer-review

3. Biomarker testing in oncology - Requirements for organizing external quality assessment programs to improve the performance of laboratory testing: revision of an expert opinion paper on behalf of IQNPath ABSL

   IQNPath ABSL, Dufraing, K., Fenizia, F., Torlakovic, E., Wolstenholme, N., Deans, Z. C., Rouleau, E., Vyberg, M., Parry, S., Schuuring, E. & Dequeker, E. M. C., 2020, In : Virchows Archiv : an International Journal of Pathology. p. 1-13 13 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Non-small cell lung cancer infiltrated with chronic myelomonocytic leukemia: a molecular diagnostic challenge to recognize mixed cancers in a single biopsy

   Koopman, B., Hiddinga, B. I., Platteel, I., Kluiver, J. L., Timens, W., Mulder, A. B., van Doesum, J. A., Schuuring, E., Diepstra, A. & Kempen, L. C. V., 6-Jan-2021, In : Histopathology.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Staining Performance of ALK and ROS1 Immunohistochemistry and Influence on Interpretation in Non-Small-Cell Lung Cancer

   Keppens, C., von der Thuesen, J., Pauwels, P., Ryska, A., ' t Hart, N., Schuuring, E., Miller, K., Thunnissen, E., Zwaenepoel, K. & Dequeker, E. M. C., Dec-2020, In : Journal of molecular diagnostics. 22, 12, p. 1438-1452 15 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (255) »

1. Dataset: Inter-laboratory agreement of the Cervista HPV HR test with a second cut-off at default setting of 1.93 (A) and at new setting of 5.0 (B)

   Boers, A. (Creator), Slagter-Menkema, L. (Creator), Hemel, van, B. (Creator), Belinson, J. L. (Creator), Ruitenbeek, T. (Creator), Buikema, H. (Creator), Klip, H. (Creator), Ghyssaert, H. (Creator), Zee, van der, A. (Creator), Bock, de, T. (Creator), Schuurs-Wisman, B. (Creator) & Schuuring, E. (Creator), University of Groningen, 22-Jul-2014

   DOI: https://doi.org/10.1371/journal.pone.0101930.t006

   Dataset

View all (1) »

1. Circulating plasma DNA biomarker

   Ed Schuuring (Invited speaker)

   30-Apr-2015

   Activity: Talk or presentation › Academic

2. De longkankercel, kennis vanuit de medisch pathologische oncologie

   Ed Schuuring (Invited speaker)

   17-Apr-2015

   Activity: Talk or presentation › Professional

3. Basale moleculaire biologie in onze diagnostiek

   Ed Schuuring (Invited speaker)

   30-Sep-2015 → 1-Oct-2015

   Activity: Talk or presentation › Professional

View all (80) »

1. (Moleculair) diagnostisch onderzoek bij de Pathologie kan nieuwe behandelmogelijkheden bieden voor longkankerpatiënten.

   Wim Timens & Ed Schuuring

   16/11/2019

   1 Media contribution

   Press/Media: Expert Comment › Popular

2. 3D-eiwit model van nieuwe genetische veranderingen in een tumormutaties draagt bij aan een betere voorspelling van de effectiviteit van longkanker behandeling.

   Wim Timens & Ed Schuuring

   12/11/2019

   1 Media contribution

   Press/Media: Expert Comment › Popular

3. diagnostisch onderzoek naar longkanker kan nieuwe/betere behandelmethode bieden

   Ed Schuuring

   11/11/2019 → 12/11/2019

   2 Media contributions

   Press/Media: Expert Comment › Professional

View all (8) »